Author details

Full Name

Megan McCausland

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34708658	With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials.	Bioanalysis	2021
32661157	Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans.	Proc Natl Acad Sci U S A	2020
32792465	Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination.	Science	2020
29743372	Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.	J Virol	2018
28207986	Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.	Influenza and other Respiratory Viruses	2017
28502771	Metabolic Phenotypes of Response to Vaccination in Humans.	Cell	2017
28446615	Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2017
29236685	Origin and differentiation of human memory CD8 T cells after vaccination.	Nature	2017
28108183	Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.	Journal of Virological Methods	2017
25157133	Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.	Proc Natl Acad Sci U S A	2014
24675761	Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.	PLoS Pathog	2014
23405860	Cross-reactive humoral responses to influenza and their implications for a universal vaccine.	Ann N Y Acad Sci	2013
24030473	Identification of novel markers for mouse CD4(+) T follicular helper cells.	Eur J Immunol	2013
22615367	Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.	Proc Natl Acad Sci U S A	2012
22647789	Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.	mBio	2012
21743478	Systems biology of vaccination for seasonal influenza in humans.	Nat Immunol	2011
21220454	Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.	J Exp Med	2011
21311110	Protective murine and human monoclonal antibodies against eczema vaccinatum.	Antiviral Therapy	2011
20587859	Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.	Antiviral Therapy	2010
19822230	The smallpox vaccine induces an early neutralizing IgM response.	Vaccine	2009
19019965	Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement.	Journal of Virology	2009
19793826	Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.	Journal of Virology	2009
18549802	Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.	Immunity	2008
17920702	Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo.	Journal of Virological Methods	2008
18234801	Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.	J Virol	2008
17202343	SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase.	Journal of Immunology	2007
16788096	Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease.	Blood	2006
16365421	Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.	J Immunol	2006
16140750	Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.	Journal of Virology	2005
15181282	Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.	Immunologic Research	2004
12727643	CD137-mediated T cell co-stimulation terminates existing autoimmune disease in SLE-prone NZB/NZW F1 mice.	Annals of the New York Academy of Sciences	2003
12750400	CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.	Journal of Clinical Investigation	2003